Josh Feng

University of Utah - David Eccles School of Business

1645 E Campus Center Dr

Salt Lake City, UT 84112-9303

United States

National Bureau of Economic Research

1050 Massachusetts Avenue

Cambridge, MA 02138

United States

SCHOLARLY PAPERS

5

DOWNLOADS

505

SSRN CITATIONS

2

CROSSREF CITATIONS

6

Scholarly Papers (5)

1.

Crafting Intellectual Property Rights: Implications for Patent Assertion Entities, Litigation, and Innovation

Feng, Josh, and Xavier Jaravel. 2020. "Crafting Intellectual Property Rights: Implications for Patent Assertion Entities, Litigation, and Innovation." American Economic Journal: Applied Economics, 12 (1): 140-81.
Number of pages: 79 Posted: 13 Sep 2016 Last Revised: 20 Mar 2020
Josh Feng and Xavier Jaravel
University of Utah - David Eccles School of Business and London School of Economics & Political Science (LSE) - Department of Economics
Downloads 278 (120,063)
Citation 9

Abstract:

Loading...

Innovation, Litigation, Examiners

2.

Pricing Intermediaries in Prescription Drug Markets: To Leverage or Replace?

Number of pages: 69 Posted: 28 Jan 2019 Last Revised: 30 Apr 2020
Josh Feng
University of Utah - David Eccles School of Business
Downloads 90 (308,701)

Abstract:

Loading...

Drug Pricing, Pharmacy Benefit Managers, Formulary Design, Medicare Part B, Medicare Part D, Dynamic Games, Dynamic Pricing, Consumer Inertia

3.

Innovating for People Like Me: Evidence from Female-Founded Consumer Packaged Goods Startups

Number of pages: 41 Posted: 24 May 2019
Josh Feng and Xavier Jaravel
University of Utah - David Eccles School of Business and London School of Economics & Political Science (LSE) - Department of Economics
Downloads 80 (331,973)

Abstract:

Loading...

Entrepreneurship, Innovation, New Goods, Product Variety, Economics of Ideas

4.

History-Dependence in Drug Demand: Implications for Entry Timing

Number of pages: 79 Posted: 28 Jan 2019 Last Revised: 14 Apr 2020
Josh Feng
University of Utah - David Eccles School of Business
Downloads 38 (469,552)

Abstract:

Loading...

Prescription Drug Demand, Inertia, History-Dependence, Generic Drugs, Line Extensions, Firm Strategy, Entry Timing

5.

Profiting from Most-Favored Customer Procurement Rules: Evidence from Medicaid

Number of pages: 50 Posted: 20 Mar 2020 Last Revised: 13 Jul 2020
Josh Feng, Thomas Hwang and Luca Maini
University of Utah - David Eccles School of Business, affiliation not provided to SSRN and UNC Chapel Hill
Downloads 19 (573,205)
Citation 1

Abstract:

Loading...

Medicaid, Pharmaceutical Market, Bargaining, Most-Favored Customer Clauses, Procurement